With the analysis among 745 patents, we discovered top 153 key players by total patent application. The General Hospital Corp., Pioneer Hi-Bred International, Inc., Cellectis SA are dominant in this area. They take 19.06% of the total patent filing.
The General Hospital Corp.
Massachusetts, United States
Patent: 75
Pioneer Hi-Bred International, Inc.
Iowa, United States
Patent: 39
Modalis Therapeutics Corp.
Tokyo-to, Japan
Patent: 27
TET Systems GmbH & Co. KG
Baden-Württemberg, Germany
Patent: 25
Delaware, United States
Patent: 21
Delaware, United States
Patent: 19
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 18
Hovedstaden, Denmark
Patent: 16
With the analysis among 48 patents, we discovered top 7 start-ups by total patent application. Modalis Therapeutics Corp., Impossible Foods, Inc., Zumutor Biologics, Inc. are active in this area.
Modalis Therapeutics Corp.
Tokyo-to, Japan
Patent: 27
California, United States
Patent: 9
Massachusetts, United States
Patent: 6
Institut National de la Santé et de la Recherche Médicale
California, United States
Patent: 1
With the analysis among related 263 patents applied in the last 5 years. We discover 89 most active companies in this area. The fast-growing Modalis Therapeutics Corp., Danisco US, Inc., Regeneron Pharmaceuticals, Inc. take 25.10% of patent filing during this period.
Modalis Therapeutics Corp.
Tokyo-to, Japan
Patent: 27
Delaware, United States
Patent: 21
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 18
The General Hospital Corp.
Massachusetts, United States
Patent: 18
Tokyo-to, Japan
Patent: 13
President & Fellows of Harvard College
Massachusetts, United States
Patent: 12
Regents of the University of California
California, United States
Patent: 11
North Carolina, United States
Patent: 10
Nanjing Advanced Biomaterials and Process Equipment Research Institute Co., Ltd.
Jiangsu Sheng, China
Patent: 8
Minnesota, United States
Patent: 6
With the analysis among related 263 patents in last 5 years, we discover 58 new entrants. Modalis Therapeutics Corp., Danisco US, Inc., Regeneron Pharmaceuticals, Inc. are the most active new entrants in this area.
Modalis Therapeutics Corp.
Tokyo-to, Japan
Patent: 27
Delaware, United States
Patent: 21
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 18
Tokyo-to, Japan
Patent: 13
Nanjing Advanced Biomaterials and Process Equipment Research Institute Co., Ltd.
Jiangsu Sheng, China
Patent: 8
Massachusetts, United States
Patent: 4
Victoria, Australia
Patent: 4
Shandong Sheng, China
Patent: 3
Altius Institute For Biomedical Sciences
Washington, United States
Patent: 3
With the analysis among 516 patents, we discovered top 83 universities and scientific research institutions by total patent application. President & Fellows of Harvard College, University of Minnesota, Duke University are dominant in this area. They take 28.49% of the total patent filing.
President & Fellows of Harvard College
Massachusetts, United States
Patent: 79
Minnesota, United States
Patent: 37
North Carolina, United States
Patent: 18
Michigan Technological University
Michigan, United States
Patent: 14
The Rockefeller University
New York, United States
Patent: 12
The Johns Hopkins University
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 10
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 9
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 9
University of South Florida